LLyrebird Health builds tools to automatically generate medical documentation, freeing clinicians from hours of typing so they can focus on the patient. It creates patient notes and other relevant clinical documents without requiring manual data entry, enabling clinicians to listen more closely during visits. This product differentiates itself by targeting providers who prioritize high-quality patient care and by removing administrative friction that disrupts the patient encounter. The overall goal is to improve the quality of care by reducing writing overhead and letting clinicians devote more time to the patient.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$7.8M
Headquarters
Melbourne VIC, Australia
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$7.8M
Below
Industry Average
Funded Over
2 Rounds
Industry standards
Barnsley Hospital NHS awards ambient voice contract. November 9, 2026 8:09 am Barnsley Hospital NHS Foundation Trust has awarded a contract for ambient voice technology acute licenses, set to run from November 2026 to February 2028, to Lyrebird Health. Board papers from September highlight the pilot of AVT across clinical areas such as outpatients and emergency care, with Barnsley noting that funding and procurement arrangements means further roll outs can be planned. In an AI policy put forward for board approval in July, the trust sets out requirements for the use of AVT for clinical documentation, including DPIA, DTAC, IT technical assurance assessment, and CSO sign-off. It also points to the need for AI-generated clinical documentation to be identifiable in the record, allowing subsequent reviewers to interpret the document with "appropriate context". On the wider use of AI, Barnsley outlines that AI systems should not be "deploy-and-forget" technologies. There should be ongoing monitoring and lifecycle management in place, it continues, such as model drift monitoring, periodic reviews of accuracy and clinical safety, and a trust-wide register of AI systems in use. Last year, the trust published its annual report, highlighting the impact of its other digital investments, such as digital clinic notes and ED documentation on patient experience and clinical care. It shared that investments made in digital technologies in 2024/25 had supported it in sending 64,000 letters per month digitally to patients and partners, delivering up to 25 percent of its total appointments virtually, creating 910,000 digital healthcare documents as part of its paper to digital programme, and scanning 97 million pages of clinical paper notes. Clinical documentation in the emergency department went live in July 2024, followed by electronic prescribing in October 2024. A digital maternity solution, Badgernet Maternity, was introduced to support a fully integrated and digitally accessible digital record for expectant mothers. The roll-out of inpatient medical notes was also completed in February 2025, with further "significant inroads" made into theatre and surgery digital noting, and plans to fully digitise nursing documentation over the coming year. Wider trend: AVT Digital Health and Care Wales has chosen to abandon its £10m ambient voice technology procurement, citing a "limited number of suppliers successfully meeting the Conditions of Participation requirements". The organisation launched the open framework agreement in August, aiming to support the adoption of the technology to improve clinical documentation processes. It shared its intent to use the exercise to maintain a "pre-qualified list" of AVT suppliers, with conditions enabling participation and the need to achieve a minimum evaluation threshold. The decision to abandon the process has been made following the completion of the Conditions of Participation assessment stage, DHCW notes, which reviewed the procurement outcome. Mid Cheshire Hospitals NHS Foundation Trust has rolled out ambient voice technology across more locations and community services following a successful trial. The initial trial of the Lyrebird AVT solution incorporated services including same day emergency care, dermatology, rheumatology, and urology. The technology will now be used in services including the emergency department, paediatrics, orthopaedics, the stroke unit, and the minor injuries unit, MCHT reports. More than 300 members of staff have been trained on using the technology so far, according to Rosie Redstone, digital senior project manager. The North West London Acute Provider Group has shared its intent to procure an ambient voice technology solution, launching a market engagement opportunity. The group, covering Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, London North West University Healthcare NHS Trust, and The Hillingdon Hospitals NHS Foundation Trust; estimates that a future contract for the solution will run from 1 April 2027 to 31 March 2030, a total of three years.
GPRA supports the next generation of GPs and RGs to practise safely and co-design clinical AI tools under new partnership. Joint media statement. 10 september 2026. Future General Practitioners will play a key role in shaping clinical AI tools under a new partnership between General Practice Registrars Australia (GPRA) and Lyrebird Health. Lyrebird Health, the Australian-owned clinical AI company behind one of the country's most widely used AI medical scribes, will establish a GPRA member national working group to co-build the future of clinical AI. GPRA President Dr Chris Dickie said this was a unique opportunity for GPRA's 22,000 members, who reflect every stage of the journey to becoming a GP or Rural Generalist (RG), to drive quality and safe digital innovation. "AI is rapidly changing the way community-based care is delivered, from the growing use of clinical documentation tools like Lyrebird to patients presenting with AI-assisted health enquiries," said Dr Dickie. "Working with Lyrebird, we can ensure the next generation of GPs and RGs can safely and confidently navigate this new technology and directly contribute to its development. "This exciting new partnership gives future GPs and RGs a seat at the table shaping the tools they will use for the rest of their careers." Lyrebird spokesperson Dr Ray Boyapati said the doctors currently in training have more at stake in how clinical AI is adopted than any other group in general practice. "They are forming the clinical and technology habits that will shape how medicine is practised for decades to come, and they are doing it at the moment clinical AI moves from novelty to everyday tool," said Dr Boyapati. "That transition is already happening. What's missing is guidance, confidence and a trusted point of view. "This is a long-term commitment, not a one-off. We'll be working with GPRA members to understand what they actually need from clinical AI and what genuinely works in everyday practice. "The doctors using these tools should be the ones shaping them, and that's what we're building with GPRA." Commencing from 2027, the partnership also provides GPRA members with 12 months' free access to a Lyrebird Pro and an AI-confidence curriculum covering AI-safe practice, billing confidence and portfolio careers. Dr Dickie said the Lyrebird benefits join GPRA's growing list of exclusive offers and resources to support members' training and careers. "AI scribes are an exciting tool that I use in my own practice, allowing me to better focus on my patients and save time on administrative tasks," said Dr Dickie, a newly-Fellowed GP working in New South Wales. "Like any tool you use in medical practice or training, it's important to discuss its use with your manager or supervisor, and follow the guidelines of your practice, training college, hospital or medical school." About GPRA: General Practice Registrars Australia (GPRA) is the national independent voice for future GPs and RGs in Australia (www.gpra.org.au). About Lyrebird Health: Lyrebird Health is a clinical AI platform built to help clinicians do more than document the consult, supporting the administrative work involved in clinical care and connecting with the systems already used to deliver it (www.lyrebirdhealth.com/au).
Lyrebird Health, a Melbourne-based company, has completed a funding round led by Five V Capital and Octopus Ventures to enhance its AI-powered medical scribe platform. The funds will support global expansion, regulatory compliance, and integration with electronic medical records. The company is expanding operations in the UK and Middle East, partnering with hospitals to refine its technology. This development aligns with broader innovation in the healthcare sector, impacting ASX 200 healthcare-linked equities.
AI-backed medical scribe Lyrebird Health raises $12m as fast-growing startup eyes UK and Middle East.
Lyrebird Health says more than 99 per cent of patients consent to their appointments being recorded by its medical scribe software.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$7.8M
Headquarters
Melbourne VIC, Australia
Founded
2023
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs